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Introduction
Stress conditions stimulate a variety of responses in eukaryotic 
cells, ranging from stress neutralization to cell death. Recent 
studies have described a novel aspect of stress responses in   
eukaryotic cells wherein cytosolic tRNAs are separated into 
half molecules by cleavage in the anticodon loop. Such tRNA 
cleavage has been observed during amino acid starvation in   
Tetrahymena thermophila and Aspergillus fumigatus (Lee and 
Collins, 2005; Jochl et al., 2008), during development in the 
bacterium Streptomyces coelicolor (Haiser et al., 2008), and in 
human, plant, and yeast systems during oxidative stress (Thompson   
et al., 2008; see Yamasaki et al. on p. 35 of this issue). More­
over, large­scale small RNA sequencing studies have identified   
cleaved tRNAs in human cells (Kawaji et al., 2008). Interest­
ingly, tRNA fragments are also observed in the urine and sera   
of cancer patients, with levels correlated with the tumor burden 
(Waalkes et al., 1975; Borek et al., 1977; Speer et al., 1979; 
Tamura et al., 1987). An unresolved issue is the mechanism and 
significance of stress­induced tRNA cleavage.
We demonstrate that cytosolic RNAs in yeast are cleaved 
during oxidative stress by release of the endonuclease RNase in 
Yeast 1 (Rny1p) from the vacuole into the cytosol. Rny1p also 
modulates cell survival during oxidative stress, but this effect is 
independent of its catalytic ability. These observations argue that 
release of Rny1p from the vacuole both promotes tRNA cleavage 
and separately activates a downstream pathway that promotes cell 
death. This is analogous to the classical example of cytochrome c 
release from mitochondria promoting apoptosis, and may be   
a general principle of how cells sense damage to membrane­
bound compartments. Strikingly, the human orthologue of Rny1p,   
RNASET2, is a tumor suppressor that functions in a manner inde­
pendent of its catalytic activity (Acquati et al., 2005; Smirnoff   
et al., 2006), which suggests that a similar control circuit occurs 
in mammalian cells and impacts on tumor progression.
Results and discussion
The endonuclease Rny1p is responsible for 
tRNA cleavage
To identify the endonuclease responsible for tRNA cleavage, 
we screened several mutant yeast strains lacking predicted endo­
nucleases for their effect on tRNA cleavage during H202 exposure 
or entry into stationary phase, when tRNA fragments are easily   
detected (Thompson et al., 2008). Only strains lacking RNY1, 
which is a member of the RNaseT2 family (MacIntosh et al., 2001), 
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Rny1p can also cleave ribosomal RNAs 
(rRNAs)
rRNA fragments are also detected in yeast, and increased rRNA 
fragment levels are observed during oxidative stress conditions 
(Thompson et al., 2008). Therefore, we asked whether loss   
of Rny1p also affects rRNA fragment levels during oxidative 
stress, using a probe against the 3 end of the 25S rRNA that 
corresponds to a common rRNA cleavage product (Fig. 1, E and F, 
arrows; Thompson et al., 2008). We observed that the rny1∆ 
strain did have fewer rRNA fragments overall, but rRNA frag­
ments were still observed (Fig. 1, E and F). This demonstrates 
that Rny1p can affect rRNA fragment production, but that there 
failed to produce tRNA fragments during oxidative stress, entry   
into stationary phase, or other stress conditions (Fig. 1, A and B; 
and not depicted). tRNA fragment production in the rny1 
strain can be rescued by providing RNY1 on a plasmid, and is 
increased when RNY1 is overexpressed from the GAL promoter 
(Fig. 1 C). Rny1p is likely to directly cleave tRNAs, as expression 
of a catalytically inactive version (rny1-ci), with two key histidine 
residues in the active site replaced by phenylalanines (H87F and 
H160F; Deshpande and Shankar, 2002; Acquati et al., 2005), 
fails to restore tRNA fragment production in an rny1∆ strain 
(Fig. 1 D). These observations argue that Rny1p is the nuclease 
cleaving tRNAs in yeast.
Figure 1.  Rny1p is the endonuclease responsible for yeast tRNA cleavage. (A) 5 tRNA-His(GTG) probe. tRNA cleavage in WT yeast during stationary 
phase entry. WT yeast were grown for 6 d. (B) 5 tRNA-His(GTG) probe. tRNA cleavage does not occur in yeast lacking RNY1. rny1 yeast were grown 
as in A. The contrast in panels A and B were adjusted to similar levels to facilitate comparison. (C) 3 tRNA-Met(CAT) probe. Expression of RNY1 from a 
plasmid restores tRNA cleavage. The pGAL-RNY1 vector (+) or the empty vector pRS426 () were transformed into WT and rny1 cells. Yeast were grown 
to mid-log phase. (D) 3 tRNA-Met(CAT) probe. Overexpression of rny1-ci in rny1 cells does not rescue tRNA cleavage; compare this with the overexpres-
sion of RNY1. Yeast were grown as in C. (E) 3 25s rRNA probe (arrow). rRNA cleavage in WT yeast during stationary phase entry. This is a reprobing of 
the blot shown in A. (F) 3 25s rRNA probe (arrow). rRNA cleavage in rny1 yeast during stationary phase entry. This is a reprobing of the blot shown in B. (G) 
3 tRNA-GluD probe. tRNA cleavage does not occur during postharvest cell lysis. WT (yRP840) and rny1 strains carrying a D. discoideum tRNA (tRNA-
GluD) were cocultured or grown separately for 3 d in selective medium. (H) 5 tRNA-His(GTG) probe. Overexpression of human RNASET2 in an rny1 
strain rescues tRNA cleavage. Yeast were grown as in C. tRNA illustrations indicate full-length and fragment species. L = X174/Hinf 1 ladder (sizes are 
indicated in nucleotides). Experiments were repeated at least three times; representative blots are shown.45 RNY1P PROMOTES CELL DEATH DURING OXIDATIVE STRESS • Thompson and Parker
results suggest that Rny1p is distributed in the cytosol, which 
provides a mechanism by which Rny1p could access tRNAs 
and rRNAs for cleavage.
are likely to be additional nucleases that can act on rRNA dur­
ing oxidative stress. That Rny1p is able to cleave other RNAs in 
addition to tRNAs is consistent with work showing that T2   
RNases have broad specificity (Deshpande and Shankar, 2002).
Rny1p does not act in trans
Rny1p contains a putative N­terminal signal peptide for entry 
into the secretory pathway and is thought to be a secreted pro­
tein (MacIntosh et al., 2001), but it also accumulates in yeast 
vacuoles (see the following paragraph). This partitioning of 
Rny1p away from the cytosol raised the possibilities that tRNA 
cleavage was either an artifact of cell lysis, with extracellular 
or vacuolar Rny1p interacting with tRNAs released from the 
cytoplasm during lysis, or that Rny1p could be transferred   
between cells. To test these possibilities, we cocultured two 
yeast  strains:  an  rny1  strain  expressing  a  Dictyostelium 
discoideum tRNA (referred to as tRNA­GluD; Shaheen and   
Hopper, 2005), and a wild­type (WT) strain lacking tRNA­
GluD. We observed that tRNA­GluD is not cleaved by Rny1p 
provided in trans, although when tRNA­GluD is expressed in a 
WT strain, tRNA­GluD fragments are clearly visible (Fig. 1 G). 
This demonstrates that Rny1p­mediated tRNA cleavage only 
occurs within cells expressing Rny1p and is not an artifact of   
cell lysis.
Vacuolar release of Rny1p correlates with 
tRNA cleavage
An unresolved issue was how cytoplasmic tRNAs and secreted 
or vacuolar localized Rny1p might interact. One possibility was 
that tRNAs enter the vacuole during stress conditions, possibly 
via autophagy (Scherz­Shouval and Elazar, 2007). However, 
tRNA fragment production is identical in autophagy­deficient 
and WT yeast strains (Fig. S1). A second possibility was that 
oxidative stress induces release of Rny1p from the vacuole into 
the cytoplasm. To address this issue, we localized a GFP­tagged 
version of Rny1p before and during oxidative stress.
In the absence of oxidative stress, Rny1p was primarily 
concentrated in the vacuole, as assessed by colocalization with 
the  vacuolar  luminal  dye  7­amino­4­chloromethylcoumarin 
(CMAC; Fig. 2 A). Smaller puncta of Rny1p are also observed, 
which may be vesicles involved in Rny1p biogenesis, as ex­
pected for a protein with a secretion peptide. After H2O2 expo­
sure,  the  level  of  Rny1p  in  the  vacuole  is  reduced,  which 
suggests that Rny1p is delocalized from the vacuole during 
stress. Vacuolar exit does not appear to be the result of stress­
induced lysis or breakdown of the vacuole, as the luminal 
CMAC dye is retained in vacuoles during oxidative stress 
(Fig. 2 A). Moreover, by Western blot analysis, the amount of 
Rny1p does not appreciably decline after exposure to oxida­
tive stress, which argues that loss of the vacuolar signal is not 
caused by degradation of Rny1 protein (Fig. 2 B). The strongly 
fluorescent puncta observed after H2O2 treatment do not repre­
sent a novel cytosolic location for Rny1p, as they colocalize 
with mitochondria, and are present even in control strains with­
out a GFP­tagged protein (Fig. S2 A), which suggests mito­
chondrial autofluorescence, possibly from oxidized flavoproteins 
(see Foster et al., 2006). Therefore, after oxidative stress, our 
Figure 2.  Rny1p localization before and during oxidative stress. (A) Local-
ization of Rny1p-GFP during log phase and after a 20-min exposure to   
3 mM H2O2. (B) Western blot analysis of Rny1p-GFP or Pep4p-GFP levels 
in cells before and after 1 h exposure to 3 mM H2O2. Approximate   
molecular masses are indicated in kD. (C) Localization of Pep4p-GFP dur-
ing log phase and after a 20-min exposure to 3 mM H2O2. The vacuolar   
luminal dye CMAC was used to mark vacuoles. Experiments were repeated 
at least three times; representative examples are shown.JCB • VOLUME 185 • NUMBER 1 • 2009   46
To determine whether Rny1p is unique in being released 
from vacuoles during oxidative stress, we examined whether 
GFP­tagged versions of the vacuolar proteases Pep4 and Prc1, or 
the luminal protein Npc2 were also released into the cytosol after 
oxidative stress. We observed that all three of these vacuolar   
proteins are concentrated in vacuoles during log­phase growth 
(Fig. 2 C and Fig. S3, A and B). During oxidative stress condi­
tions, these proteins, like Rny1p, decline in concentration in the 
vacuole and increase in the cytosol (as assessed away from the 
mitochondrial background), although their overall levels do not 
significantly decline during oxidative stress (Fig. 2 B and Fig. 
S3 C). These observations indicate that during oxidative stress, 
multiple proteins are released from the vacuole, presumably be­
cause of damage to, or increased permeability of, the vacuolar 
membrane. Moreover, this release of proteins from the vacuole is 
likely to be conserved, as previous studies have indicated that 
human lysosomal proteins are released during oxidative stress 
(for review see Guicciardi et al., 2004).
Rny1p promotes cell death
Because oxidative stress can promote apoptosis and also resulted 
in high levels of tRNA cleavage, we hypothesized that Rny1p 
and/or tRNA cleavage might contribute to cell death. To examine 
this possibility, we first determined the effects of overexpression or 
deletion of RNY1 on yeast undergoing oxidative stress, either from 
entry into stationary phase or from exogenously added H2O2.   
We observed that strains overexpressing RNY1 show reduced 
viability as cells enter stationary phase (Fig. 3 A). Additionally, 
yeast overexpressing RNY1 are hypersensitive to oxidative stress 
from H2O2 exposure (Fig. 3 B). This suggests that overexpression 
of RNY1 hypersensitizes cells to oxidative stress, thus promoting 
cell death during peroxide exposure and stationary phase onset.
Expression of human RNASET2 in  
yeast results in tRNA cleavage and a 
growth defect
Because tRNA cleavage during oxidative stress is conserved 
among eukaryotes (Thompson et al., 2008; Yamasaki et al., 2009), 
we hypothesized that orthologues of Rny1p might be responsible 
for tRNA cleavage in other organisms. To begin to address this 
issue, we examined the effects of expressing the human ortho­
logue of RNY1, RNASET2, in an rny1 yeast strain. We observed 
that overexpression of RNASET2 restores tRNA fragment pro­
duction in an rny1∆ yeast strain (Fig. 1 H) and confers a similar 
loss of viability in response to oxidative stress, as does over­
expression of RNY1 (Fig. 3 C). siRNA knockdowns of RNASET2 
levels in human cells do not reduce tRNA cleavage during stress 
conditions (unpublished data; Yamasaki et al., 2009), which is 
consistent with the angiogenin nuclease playing a predominant 
role in stress­induced tRNA cleavage in mammalian cells (Fu   
et al., 2009; Yamasaki et al., 2009). However, the ability of RNA­
SET2 to complement an rny1∆ strain suggests that RNASET2 
may have some role in tRNA cleavage in mammalian cells.
Figure 3.  RNY1 promotes cell death during stationary phase and oxida-
tive stress. (A) Overexpression of RNY1 affects viability. Yeast carrying the 
pGAL-RNY1 (OE RNY1) or an empty vector were grown for the indicated   
number of days. 10-fold serial dilutions of cells were plated. (B) Over-
expression of RNY1 sensitizes cells to oxidative stress. Indicated strains were 
grown to mid-log phase, then exposed to 0 or 3 mM H2O2 for 1 h. 10-fold 
serial dilutions were plated. (C) Overexpression of human RNASET2 in an 
rny1 strain results in a growth defect. Yeast carrying the pGAL-RNY1 (OE   
RNY1), the pGAL-RNASET2 (OE RNASET2), or vector were grown as in A. 
10-fold serial dilutions were plated. (D) Deletion of RNY1 rescues the 
bir1 growth defect. Indicated strains were grown for 3 d, then 10-fold 
serial dilutions were plated. (E) Overexpression of RNY1 exacerbates the 
bir1 growth defect. bir1 cells carrying either the pGAL-RNY1 plasmid 
(OE RNY1) or vector were grown for 3 d, then 10-fold serial dilutions were 
plated. (F) Overexpression of RNY1 exacerbates the yap1 growth defect 
in response to oxidative stress. yap1 cells carrying either the pGAL-RNY1 
plasmid (OE RNY1) or vector were grown as in E. Experiments were   
repeated at least three times; representative experiments are shown. pRS426 
was the empty vector control.
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during oxidative stress (Fig. S2, B and C). Thus, rny1p­ci behaves 
similarly to WT Rny1p but is unable to cleave RNAs.
Examination of the phenotype of cells expressing rny1-ci 
led to two important observations. First, like WT RNY1, over­
expression of rny1-ci reduces cell viability in response to station­
ary phase entry or peroxide stress, or in a yap1 or bir1 strain 
(Fig. 4 and unpublished data). Second, expression of RNY1  
or rny1-ci at endogenous levels in the bir1 rny1 strain sup­
pressed the enhanced viability conferred by deletion of RNY1 
(compare Fig. 4 D to Fig. 3 E). These results demonstrate that 
the effects of Rny1p on growth are independent of its nuclease 
activity, similar to the role of RNASET2 in tumor suppression 
in mammalian cells.
A conserved control circuit controlling 
cytosolic RNA cleavage and cell fate
Our results describe a control circuit that modulates the re­
sponse to oxidative stress, affecting both cytosolic RNA cleav­
age and, separately, cell fate. This circuit has the following key 
features (Fig. 5). First, oxidative stress prompts relocalization 
of Rny1p, as well as other vacuolar proteins (Mason et al., 
2005), from the vacuole to the cytosol (Fig. 2). Second, the pres­
ence of Rny1p in the cytosol allows tRNA cleavage, as well as 
Rny1p and yeast apoptosis
WT and rny1∆ cells showed similar viability during entry into 
stationary phase and after H2O2 treatment (unpublished data), 
which suggests that the role of Rny1p in cell death is not limit­
ing under these conditions. However, if Rny1p plays a signifi­
cant, but nonlimiting, role in promoting cell death, then the loss 
of Rny1p might be expected to suppress mutations that predis­
pose yeast cells to premature apoptosis. The yeast protein Bir1 
is an apoptotic inhibitor, and the bir1 strain shows both in­
creased cell death in response to stress and a growth defect due 
to premature cell death (Walter et al., 2006). Strikingly, we ob­
served that deletion of RNY1 suppressed the growth defect of 
a bir1∆ mutant strain, resulting in increased viability (Fig. 3 D). 
Moreover, overexpression of RNY1 exacerbates the sensitivity 
of bir1 yeast to oxidative stress (Fig. 3 E). In similar fashion, 
overexpression of RNY1 also increases the sensitivity of yap1 
yeast to oxidative stress (Fig. 3 F), Yap1p being a key factor   
in the response to oxidative stress in yeast (Ikner and Shiozaki, 
2005). The fact that deletion of RNY1 suppresses the premature 
death of the bir1∆ strain, and that overexpression of RNY1  
hypersensitizes yap1 and bir1 cells to oxidative stress, indi­
cates that Rny1p contributes to the modulation of cell survival 
during oxidative stress.
The role of Rny1p in cell death is 
independent of its catalytic activity
The similarity of tRNA cleavage in yeast and mammalian   
cells, and the ability of the human orthologue RNASET2 to 
complement an rny1∆ yeast strain, suggested that the biological 
response to oxidative stress involving these nucleases is a con­
served process. Previous work has shown that additional ex­
pression of RNASET2, or addition of recombinant RNASET2 
protein, inhibits colony formation and metastasis of tumor cell 
lines, though in a manner independent of the catalytic activity 
of RNASET2 (Acquati et al., 2001, 2005; Smirnoff et al., 2006). 
This suggested two possible overlapping mechanisms by which 
Rny1p could influence cell fate. In one, release of Rny1p from 
the vacuole increases tRNA cleavage, resulting in an inhibition 
of cellular function, either by the reduction of critical RNA lev­
els or by the tRNA fragments themselves having an inhibitory 
function. Alternatively, in a manner similar to release of cyto­
chrome c from the mitochondria triggering apoptosis (for re­
view see Eisenberg et al., 2007), movement of Rny1p out of the 
vacuole could inhibit cellular function in a manner independent 
of its nuclease activity, possibly as part of a mechanism to sense 
vacuolar damage.
To distinguish between these possibilities, we generated   
a catalytically inactive form of Rny1p (rny1p­ci) by replacing 
two highly conserved residues in the catalytic core. Similar   
mutations in other RNase T2 family members inactivate the   
enzyme (Deshpande and Shankar, 2002; Acquati et al., 2005). 
Overexpression of rny1-ci does not rescue tRNA fragment pro­
duction in an rny1 mutant strain (Fig. 1 D), which demon­
strates that these mutations inhibit the nuclease activity of 
Rny1p. However, rny1­ci protein is expressed at levels similar 
to WT Rny1p (both expressed from the GAL promoter), local­
izes to the vacuole during mid­log phase growth, and is released 
Figure 4.  Catalytically inactive and WT RNY1 both promote cell death 
during oxidative stress. (A) Overexpression of RNY1 or rny1-ci results in 
a growth defect. Indicated strains were grown for 3 d, then 10-fold se-
rial dilutions of cells were plated to assess viability. (B) Overexpression of 
RNY1 or rny1-ci sensitizes cells to oxidative stress. Indicated strains were 
grown to mid-log phase and exposed to 3 mM H2O2 for 1 h, then 10-fold 
serial dilutions were plated. (C) Overexpression of RNY1 or rny1-ci exac-
erbates the yap1 growth defect in response to oxidative stress. Strains 
were grown as in A. (D) Expression of RNY1 or rny1-ci at endogenous 
levels in a bir1 rny1 strain results in reversion to the bir1 phenotype. 
Cells were grown as in A. Experiments were repeated at least three times; 
representative experiments are shown.JCB • VOLUME 185 • NUMBER 1 • 2009   48
Vacuole/lysosome homeostasis appears to affect cells and 
tumor progression in a manner consistent with our observations. 
For example, we have observed that in a yeast strain defective in 
vacuolar pH maintenance, Rny1p­GFP is not concentrated in 
vacuoles, and tRNA cleavage is increased (unpublished data). 
Moreover, lysosomal proton pumps are up­regulated in several 
human cancers, which contributes to the tendency of tumor   
microenvironments to acidity (see Fais et al., 2007). Finally, pro­
ton pump inhibitors have proven effective in inducing apoptosis 
in human tumor cells both in vitro and ex vivo by a mechanism 
involving increased permeability of the lysosomal membrane 
(De Milito et al., 2007). These observations, and the effect of 
RNASET2 on tumor progression, suggest that release of Rny1p 
or its orthologues in response to oxidative stress is not only a 
conserved process, but one that may modulate tumor progres­
sion in humans.
Materials and methods
Yeast strains and growth conditions
Strains used in this study are listed in Table S1. BY4741 (Thermo Fisher 
Scientific) was the WT strain used unless indicated. The bir1 strain was 
obtained from F. Madeo (Karl-Franzens University, Graz, Austria; Walter   
et al., 2006). Yeast were cultured at 30°C in yeast extract-peptone (YEP) 
medium with 2% glucose (YEPD) or in synthetic complete medium (SCM) 
supplemented with 2% glucose. As all plasmids used in this study carried 
a URA3 yeast auxotrophic marker, “selective SCM” indicates SC medium 
lacking uracil. For galactose induction of gene expression, strains were 
grown overnight in selective SCM containing 2% sucrose, then diluted to 
OD600 = 0.1 in fresh medium containing 2% galactose. “Mid-log phase” 
indicates growth to OD600 = 0.3–0.5. Coculturing of strains (Fig. 1 G)   
involved mixing equal amounts of cells (based on OD600) from overnight 
cultures for a total starting OD600 of 0.1. Cultures were grown for 2 d, then 
harvested for RNA.
cleavage of rRNA and potentially some mRNAs (Fig. 1). Third, 
Rny1p reduces cell growth independently of its nuclease activ­
ity (Fig. 4), presumably by affecting signaling pathways. Note 
that the accumulation of an organellar component in the cytosol 
inhibiting growth is analogous to cytochrome c release from the 
mitochondria  promoting  apoptosis  (Eisenberg  et  al.,  2007). 
Thus, the cellular response to stress involves parallel pathways 
for sensing cellular damage to membrane­bound compartments, 
the summation of which determines whether cells grow or commit 
to cell death.
Evidence suggests that a related pathway is conserved   
in mammalian cells. First, endonucleolytic cleavage of tRNAs   
in response to oxidative stress is observed in mammalian cells 
(Thompson et al., 2008; Yamasaki et al., 2009). Second, over­
expression of the human RNY1 orthologue RNASET2 both com­
plements an rny1 strain with regard to tRNA cleavage and also 
reduces yeast viability after stress (Figs. 1 H and 3 C). Third, ex­
pression of RNASET2 has been shown to affect cell growth in 
mammalian cells and to reduce the metastatic potential of tumor 
cell lines both in vivo and in vitro, independent of its nuclease ac­
tivity (Acquati et al., 2001, 2005; Smirnoff et al., 2006). Finally, 
release of lysosomal proteins into the cytosol during oxidative 
stress has been observed in mammalian cells and is thought to pro­
mote entry of cells into apoptosis (for review see Guicciardi et al., 
2004). However, the observations that angiogenin cleaves tRNAs 
during oxidative stress (Fu et al., 2009) and that tRNA fragments 
may have an additional role in inhibiting translation (Yamasaki   
et al., 2009) suggest that the mammalian process may be more 
complex. One possibility is that mammalian cells have evolved 
separate mechanisms to inhibit cell growth, using RNASET2, and 
to cleave tRNAs and alter translation, performed by angiogenin.
Figure  5.  Organellar  release  of  proteins  involved  in 
stress responses. This model compares the cytochrome c– 
apoptosis pathway to how release of Rny1p from the vac-
uole might affect cell death after stress or damage.49 RNY1P PROMOTES CELL DEATH DURING OXIDATIVE STRESS • Thompson and Parker
Microscopy
MitoTracker Red chloromethyl-X-rosamine (CMXRos) and Cell Tracker blue 
CMAC were obtained from Invitrogen. Yeast were routinely grown to mid-
log phase in selective SCM with 2% galactose; WT yeast were grown in 
SCM with 2% galactose; and those carrying GFP-tagged Npc2p, Pep4p, 
and Prc1p were grown in SCM with 2% glucose. CMAC was added at   
a final concentration of 10 nM, 30 min before the initial viewing. Mito-
Tracker was added at a final concentration of 50 µM, 15 min before the 
initial viewing. H2O2 was added to a final concentration of 3 mM for   
20 min to induce oxidative stress.
Cells were harvested and spotted onto slides for immediate micro-
scopic examination. All images were acquired using a Deltavision RT   
microscope system running softWoRx 3.5.1 software (Applied Precision, 
LLC), using a 100×, oil immersion, 1.4 NA objective lens (Olympus). Im-
ages were acquired as z-series stacks of 10–15 images, and collected as 
512 × 512 pixel files with a CoolSnapHQ camera (Photometrics) using 
2 × 2 binning. All images (except those in Fig. S3 B, which were not   
deconvolved but otherwise treated identically) were deconvolved using 
standard softWoRx deconvolution algorithms (enhanced ratio, low noise 
filtering). ImageJ (National Institutes of Health) was used to collapse stacks 
to a single image and to adjust images to equal contrast ranges for each 
fluorochrome within individual experiments.
Online supplemental material
Fig. S1 shows that autophagy defects do not appear to affect tRNA frag-
ment  production.  Fig.  S2  documents  mitochondrial  autofluorescence   
during oxidative stress and shows that rny1p-ci also localizes to vacuoles. 
Fig. S3 provides additional examples of vacuolar protein release during 
stress. Table S1 contains yeast strain information. Table S2 lists the sequences 
of oligos used in this study. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200811119/DC1.
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